Prospeo
Hero Section BackgroundHero Section Background
Cell BioEngines, Inc

Cell BioEngines, Inc Revenue

Biotechnology ResearchFlag of US619 W 54th St, Center for Engineering and Precision Medicine, United States1-10 Employees

$

Cell BioEngines, Inc revenue & valuation

Annual revenue$342,220
Revenue per employee$86,000
Estimated valuation?$1,100,000
Total funding$1,000,000

Key Contact at Cell BioEngines, Inc

Flag of US

Alexey Bersenev

Co-Founder, CTO

Company overview

Headquarters619 W 54th St, Center for Engineering and Precision Medicine, 9th Floor, New York, NY 10019, US
Phone number+16178992364
Website
NAICS541714
Keywords
Oncology, Stem Cell Therapy, Regenerative Medicine, Cell & Gene Therapy, Blood Cancer, Solid Cancer, Immune Cell Therapy
Founded2022
Employees1-10
Socials

Cell BioEngines, Inc Email Formats

Cell BioEngines, Inc uses 2 email formats. The most common is {first name}_{last name} (e.g., john_doe@cellbioengines.com), used 66.7% of the time.

FormatExamplePercentage
{first name}_{last name}
john_doe@cellbioengines.com
66.7%
{first initial}_{last name}
j_doe@cellbioengines.com
33.3%

About Cell BioEngines, Inc

About Us: Cell BioEngines, Inc. founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic “off-the-shelf” stem cells and its derived therapies as ‘drugs’ for treating human diseases. The company's mission is to achieve a universal stem cell foundation platform to precisely generate any desired human cell on demand and at-scale developing unique treatments. Cell BioEngines is the only company in the world with a portfolio of patent protected universal stem cells, derived transgene-free from donor human umbilical cord. It addresses current cell therapy limitations by leveraging the development biology of stem cells to generate HLA-compatible cell products. Cell BioEngines lead product is currently in Phase 1 trials for the treatment of hematopoietic neoplasms not curable with available therapies. For more information, visit www.cellbioengines.com and follow us on www.twitter.com/cell_bioengines

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Cell BioEngines, Inc has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Cell BioEngines, Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-09-1120N/A
2023-09-112$250,000
2024-05-232$500,000
2024-08-232$250,000

Funding Insights

$1,000,000

Total funding amount

$250,000

Most recent funding amount

4

Number of funding rounds

Cell BioEngines, Inc Tech Stack

Discover the technologies and tools that power Cell BioEngines, Inc's digital infrastructure, from frameworks to analytics platforms.

GoDaddy

GoDaddy

Hosting

Lightbox

Lightbox

JavaScript libraries

GoDaddy Website Builder

GoDaddy Website Builder

CMS

Open Graph

Open Graph

Miscellaneous

HSTS

HSTS

Security

Vimeo

Vimeo

Video players

React

React

JavaScript frameworks

RequireJS

RequireJS

JavaScript frameworks

PWA

PWA

Miscellaneous

Frequently asked questions

Cell BioEngines, Inc is located in 619 W 54th St, Center for Engineering and Precision Medicine, US.
You can reach Cell BioEngines, Inc at +16178992364.
Cell BioEngines, Inc generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
Cell BioEngines, Inc has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Cell BioEngines, Inc was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.
Cell BioEngines, Inc has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Cell BioEngines, Inc has raised a total of $1,000,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles